DAPAGLIFLOZIN TRADE DATA ANALYSIS
Analyze Dapagliflozin export import data and locate key markets, reliable suppliers, and active buyers by utilizing Eximpedia's data-centric platform.Whether you're a supplier looking for high-demand markets or a buyer sourcing apples from reliable exporters, Eximpedia’s data-driven approach for making informed trade decisions.
DAPAGLIFLOZIN – Overview
Eximpedia analyses Dapagliflozin export import records, including data from 623 buyers and 237 suppliers. We provide an intelligence report of Apple that covers trade statistics, shipment values, quantities, exporters & importers, trade destinations, and HS codes.
Dapagliflozin Buyers, Suppliers & Shipments
Products Dapagliflozin import markets
Gain insights into Product Dapagliflozin with data on monthly import values, major importing countries, key ports, leading competitors, and active suppliers.
TOP IMPORT HS CODE
| HS CODE | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| 2932990000 | 129.11 | 26 | 0.00 |
| HETEROCYCLIC COMPOUNDS WITH OXYGEN HETERO-ATOM (S) ONLY | |||
| 30045099 | 79.78 | 46 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 30049089 | 47.19 | 47 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 30049099 | 29.63 | 238 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3004900000 | 23.67 | 73 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
TOP IMPORT COUNTRY
| COUNTRY | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| UNITED STATES | 134.95 | 383 | 0.00 |
| IRELAND | 128.83 | 21 | 0.00 |
| SWEDEN | 47.36 | 38 | 0.00 |
| INDIA | 10.61 | 156 | 0.00 |
| POLAND | 4.39 | 10 | 0.00 |
TOP IMPORT PORTS
| PORT NAME | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| BOMBAY AIR CARGO | 14.87 | 133 | 0.00 |
| BANGALORE AIR CARGO | 0.32 | 107 | 0.00 |
| HO CHI MINH CITY | 48.98 | 90 | 0.00 |
| HYDERABAD AIR CARGO | 0.39 | 85 | 0.00 |
| UA100200 | 23.66 | 70 | 0.00 |
TOP IMPORT COMPETITORS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| JV OPTIMA FARM LIMITED | 11.10 | 1 |
| ASTRAZENECA VIETNAM COMPANY LIMITED | 47.07 | 321 |
| ASTRAZENECA INDUSTRIES LLC | 128.80 | 173 |
| ASTRAZENECA PHARMA INDIA LIMITED | 17.23 | 370 |
| BRANCH OF ECO PHARMACEUTICAL JOINT STOCK COMPANY HANOI CITY | 79.77 | 94 |
TOP IMPORT SUPPLIERS
| COMPANY | USD VALUE | SHIPMENTS |
|---|
Discover the Hidden Opportunities in HS Code Dapagliflozin—access key decision-makers and detailed reports to save time and succeed.
Dapagliflozin Import Market
Explore Product Dapagliflozin with product description, import values, quantities, exporter name, country of origin and key destinations.
| HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
|---|---|---|---|---|---|---|
| 30045099 | CLINICAL RESEARCH DRUG DAPAGLIFLOZIN 10 MG OR PLACEBO 35 TABLETS/BOTTLE; LOT: 82866.3/1 RESEARCH CODE: D6402C00012 EXPIRY DATE: JUNE 30, 2026. MANUFACTURER: ASTRAZENECA PHARMACEUTICALS LP 100% NEW |  |
|
UNITED STATES | VIETNAM | 4 |
| 30045099 | CLINICAL RESEARCH DRUG BALCINRENON 15 MG OR 40 MG+DAPAGLIFLOZIN 10 MG OR PLACEBO 34 TABLETS/BOTTLE; LOT: L025174 RESEARCH CODE: D6402C00012 EXPIRY DATE: OCTOBER 31, 2024. MANUFACTURER:ASTRAZENECA AB 100% NEW | |
|
SWEDEN | VIETNAM | 6 |
| 30045099 | CLINICAL RESEARCH DRUG DAPAGLIFLOZIN 10 MG OR PLACEBO 35 TABLETS/BOTTLE; LOT: 82866.3/1 RESEARCH CODE: D6402C00012 EXPIRY DATE: JUNE 30, 2026. MANUFACTURER: ASTRAZENECA PHARMACEUTICALS LP 100% NEW | |
|
UNITED STATES | VIETNAM | 4 |
| 30045099 | CLINICAL RESEARCH DRUG BALCINRENON 15 MG OR 40 MG+DAPAGLIFLOZIN 10 MG OR PLACEBO 34 TABLETS/BOTTLE; LOT: L025174 RESEARCH CODE: D6402C00012 EXPIRY DATE: OCTOBER 31, 2024. MANUFACTURER:ASTRAZENECA AB 100% NEW | |
|
SWEDEN | VIETNAM | 6 |
| 30045099 | CLINICAL TRIAL DRUG DAPAGLIFLOZIN 10 MG OR PLACEBO 35 TABLETS/BOTTLE; LOT: 82866.3/1 RESEARCH CODE: D6402C00012 EXPIRY DATE: JUNE 30, 2026. MANUFACTURER: ASTRAZENECA PHARMACEUTICALS LP 100% NEW | |
|
UNITED STATES | VIETNAM | 6 |
| 30045099 | CLINICAL TRIAL DRUG BALCINRENON 15 MG OR 40 MG + DAPAGLIFLOZIN 10 MG OR PLACEBO 34 TABLETS/BOTTLE; LOT: L025709 RESEARCH CODE: D6402C00012 EXPIRY DATE: JANUARY 31, 2025. MANUFACTURER: ASTRAZENECA AB 100% NEW | |
|
SWEDEN | VIETNAM | 4 |
| 30045099 | CLINICAL TRIAL DRUG BALCINRENON 15 MG OR 40 MG + DAPAGLIFLOZIN 10 MG OR PLACEBO 34 TABLETS/BOTTLE; LOT: L025709 RESEARCH CODE: D6402C00012 EXPIRY DATE: JANUARY 31, 2025. MANUFACTURER: ASTRAZENECA AB 100% NEW | |
|
SWEDEN | VIETNAM | 4 |
| 30045099 | CLINICAL TRIAL DRUG DAPAGLIFLOZIN 10 MG OR PLACEBO 35 TABLETS/BOTTLE; LOT: 82866.3/1 RESEARCH CODE: D6402C00012 EXPIRY DATE: JUNE 30, 2026. MANUFACTURER: ASTRAZENECA PHARMACEUTICALS LP 100% NEW | |
|
UNITED STATES | VIETNAM | 6 |
| 30045099 | CLINICAL TRIAL DRUG BALCINRENON 15 MG OR 40 MG + DAPAGLIFLOZIN 10 MG OR PLACEBO 34 TABLETS/BOTTLE; LOT: L025174 RESEARCH CODE: D6402C00012 EXPIRY DATE: OCTOBER 31, 2024. MANUFACTURER: ASTRAZENECA AB 100% NEW | |
|
SWEDEN | VIETNAM | 6 |
| 30045099 | CLINICAL RESEARCH DRUG DAPAGLIFLOZIN 10 MG OR PLACEBO 35 TABLETS/BOTTLE; LOT: 82866.3/1 RESEARCH CODE: D6402C00012 EXPIRY DATE: JUNE 30, 2026. MANUFACTURER: ASTRAZENECA PHARMACEUTICALS LP 100% NEW | |
|
UNITED STATES | VIETNAM | 6 |
| 30045099 | CLINICAL RESEARCH DRUG BALCINRENON 15 MG OR 40 MG+DAPAGLIFLOZIN 10 MG OR PLACEBO 34 TABLETS/BOTTLE; LOT: L025174 RESEARCH CODE: D6402C00012 EXPIRY DATE: OCTOBER 31, 2024. MANUFACTURER:ASTRAZENECA AB 100% NEW | |
|
SWEDEN | VIETNAM | 2 |
| 30045099 | CLINICAL RESEARCH DRUG BALCINRENON 15 MG OR 40 MG+DAPAGLIFLOZIN 10 MG OR PLACEBO 34 TABLETS/BOTTLE; LOT: L025174 RESEARCH CODE: D6402C00012 EXPIRY DATE: OCTOBER 31, 2024. MANUFACTURER:ASTRAZENECA AB 100% NEW | |
|
SWEDEN | VIETNAM | 3 |
| 30045099 | CLINICAL RESEARCH DRUG BALCINRENON 15 MG OR 40 MG+DAPAGLIFLOZIN 10 MG OR PLACEBO 34 TABLETS/BOTTLE; LOT: L025174 RESEARCH CODE: D6402C00012 EXPIRY DATE: OCTOBER 31, 2024. MANUFACTURER:ASTRAZENECA AB 100% NEW | |
|
SWEDEN | VIETNAM | 3 |
| 30045099 | CLINICAL TRIAL DRUG DAPAGLIFLOZIN 10 MG OR PLACEBO 35 TABLETS/BOTTLE; LOT: 82866.3/1 RESEARCH CODE: D6402C00012 EXPIRY DATE: JUNE 30, 2026. MANUFACTURER: ASTRAZENECA PHARMACEUTICALS LP 100% NEW | |
|
UNITED STATES | VIETNAM | 6 |
| 30045099 | CLINICAL TRIAL DRUG BALCINRENON 15 MG OR 40 MG + DAPAGLIFLOZIN 10 MG OR PLACEBO 34 TABLETS/BOTTLE; LOT: L025174 RESEARCH CODE: D6402C00012 EXPIRY DATE: OCTOBER 31, 2024. MANUFACTURER: ASTRAZENECA AB 100% NEW | |
|
SWEDEN | VIETNAM | 2 |
| 30045099 | CLINICAL TRIAL DRUG DAPAGLIFLOZIN 10 MG OR PLACEBO 35 TABLETS/BOTTLE; LOT: 82866.3/1 RESEARCH CODE: D6402C00012 EXPIRY DATE: JUNE 30, 2026. MANUFACTURER: ASTRAZENECA PHARMACEUTICALS LP 100% NEW | |
|
UNITED STATES | VIETNAM | 4 |
| 30045099 | CLINICAL TRIAL DRUG BALCINRENON 15 MG OR 40 MG + DAPAGLIFLOZIN 10 MG OR PLACEBO 34 TABLETS/BOTTLE; LOT: L025174 RESEARCH CODE: D6402C00012 EXPIRY DATE: OCTOBER 31, 2024. MANUFACTURER: ASTRAZENECA AB 100% NEW | |
|
SWEDEN | VIETNAM | 6 |
| 30045099 | CLINICAL TRIAL DRUG DAPAGLIFLOZIN 10 MG OR PLACEBO 35 TABLETS/BOTTLE; LOT: 82866.3/1 RESEARCH CODE: D6402C00012 EXPIRY DATE: JUNE 30, 2026. MANUFACTURER: ASTRAZENECA PHARMACEUTICALS LP 100% NEW | |
|
UNITED STATES | VIETNAM | 4 |
| 30045099 | CLINICAL TRIAL DRUG BALCINRENON 15 MG OR 40 MG + DAPAGLIFLOZIN 10 MG OR PLACEBO 34 TABLETS/BOTTLE; LOT: L025174 RESEARCH CODE: D6402C00012 EXPIRY DATE: OCTOBER 31, 2024. MANUFACTURER: ASTRAZENECA AB 100% NEW | |
|
SWEDEN | VIETNAM | 6 |
Get Started with Eximpedia
Start 5 Days Free Trial
No Pay, No Delay - 5 days Your Way!
Book a Free Demo
Learn How our platform works in just 20 minutes!
Download Free Sample Report
Free Import-Export Sample data-One Click Away!
Products Dapagliflozin export markets
Discover Products Dapagliflozin with data on monthly export values, major exporting countries, key ports, leading competitors, and active buyers.
TOP EXPORT HS CODE
| HS CODE | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| 30049099 | 53.49 | 2989 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 29420090 | 21.69 | 326 | 0.00 |
| OTHER ORGANIC COMPOUNDS | |||
| 29329990 | 17.00 | 203 | 0.00 |
| HETEROCYCLIC COMPOUNDS WITH OXYGEN HETERO-ATOM (S) ONLY | |||
| 30049059 | 5.17 | 32 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 29332990 | 4.05 | 21 | 0.00 |
| HETEROCYCLIC COMPOUNDS WITH NITROGEN HETEROATOM(S) ONLY | |||
TOP EXPORT COUNTRY
| COUNTRY | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| CANADA | 25.04 | 222 | 0.00 |
| IRAQ | 12.24 | 95 | 0.00 |
| KOREA, REPUBLIC OF | 10.79 | 166 | 0.00 |
| TURKEY | 8.51 | 91 | 0.00 |
| HUNGARY | 6.32 | 12 | 0.00 |
TOP EXPORT PORTS
| PORTS | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| BOMBAY AIR CARGO | 22.88 | 1767 | 0.00 |
| DELHI AIR CARGO | 4.35 | 1101 | 0.00 |
| HYDERABAD AIR CARGO | 22.87 | 396 | 0.00 |
| AHMEDABAD AIR CARGO | 5.82 | 316 | 0.00 |
| BANGALORE AIR CARGO | 7.25 | 253 | 0.00 |
TOP EXPORT COMPETITORS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| HONOUR LAB LIMITED | 11.90 | 942 |
| MICRO LABS LIMITED | 8.91 | 6478 |
| INVENTIA HEALTHCARE LIMITED | 7.46 | 1443 |
| MSN LABORATORIES PRIVATE LIMITED | 17.05 | 6246 |
| AJANTA PHARMA LIMITED | 10.91 | 4247 |
TOP EXPORT BUYERS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| JAMP PHARMA CORPORATION | 5.69 | 674 |
| EGIS PHARMACEUTICALS PLC | 3.62 | 34 |
| AWAMEDICA | 9.42 | 131 |
| SANOVEL ILAC SANAYI VE TICARET AS | 5.49 | 35 |
| AURO PHARMA INC | 7.97 | 496 |
Access the complete database of 623 buyers and 237 suppliers with a one-time subscription plan.
Dapagliflozin Export Market
Analyze HSN Code Dapagliflozin with product description, export values, quantities, importer name, country of origin and key import destinations.
| HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
|---|---|---|---|---|---|---|
| 30049099 | ASPER INVOICE NO: ZPPL/XP/2324/473 DATE:11/03/2024 SR NO. 5 DAPAGLIFLOZIN TABLETS 10MG | |
|
INDIA | SINGAPORE | 100 |
| 30049099 | ASPER INVOICE NO : ZPPL/XP/2324/407 DATE: 06/03/2024 SR NO. 46 DAPAGLIFLOZIN TABLETS 5MG | |
|
INDIA | KENYA | 15 |
| 30049099 | ASPER INVOICE NO : ZPPL/XP/2324/407 DATE: 06/03/2024 SR NO. 42 DAPAGLIFLOZIN TABLETS 10MG | |
|
INDIA | KENYA | 100 |
| 30049099 | ASPER INVOICE NO : ZPPL/XP/2324/407 DATE: 06/03/2024 SR NO. 46 DAPAGLIFLOZIN TABLETS 5MG | |
|
INDIA | KENYA | 15 |
| 30049099 | ASPER INVOICE NO: ZPPL/XP/2324/473 DATE:11/03/2024 SR NO. 4 DAPAGLIFLOZIN TABLETS 5MG | |
|
INDIA | SINGAPORE | 2 |
| 30049099 | ASPER INVOICE NO : ZPPL/XP/2324/407 DATE: 06/03/2024 SR NO. 42 DAPAGLIFLOZIN TABLETS 10MG | |
|
INDIA | KENYA | 100 |
| 30049099 | AS PER INVOICE NO:ZPPL/XP/2324/338 DATE:09.12.2023 SR NO: 06 DAPAGLIFLOZIN TABLETS 10MG | |
|
INDIA | SINGAPORE | 30 |
| 30049099 | AS PER INVOICE NO:ZPPL/XP/2324/338 DATE:09.12.2023 SR NO: 05 DAPAGLIFLOZIN TABLETS 5MG | |
|
INDIA | SINGAPORE | 5 |
| 30049099 | ASPER INVOICE NO: ZPPL/XP/2324/222 DATE:02/12/2023 SR NO. 180 DAPAGLIFLOZIN TABLETS 10MG | |
|
INDIA | KENYA | 100 |
| 30049099 | ASPER INVOICE NO: ZPPL/XP/2324/473 DATE:22/03/2024 SR NO. 4 DAPAGLIFLOZIN TABLETS 5MG | |
|
INDIA | SINGAPORE | 2 |
| 30049099 | ASPER INVOICE NO: ZPPL/XP/2324/473 DATE:22/03/2024 SR NO. 5 DAPAGLIFLOZIN TABLETS 10MG | |
|
INDIA | SINGAPORE | 100 |
| 30049099 | ASPER INVOICE NO : ZPPL/XP/2324/407 DATE: 06/03/2024 SR NO. 42 DAPAGLIFLOZIN TABLETS 10MG | |
|
INDIA | KENYA | 100 |
| 30049099 | ASPER INVOICE NO : ZPPL/XP/2324/407 DATE: 06/03/2024 SR NO. 46 DAPAGLIFLOZIN TABLETS 5MG | |
|
INDIA | KENYA | 15 |
| 30049099 | ASPER INVOICE NO: ZPPL/XP/2324/429 DATE:14/02/2024 SR NO. 5 SITAGLIPTIN 50MG &DAPAGLIFLOZIN TABLETS 10MG | |
|
INDIA | LAO, PEOPLE`S DEMOCRATIC REPUBLIC | 50 |
| 30049099 | ASPER INVOICE NO : ZPPL/XP/2324/407 DATE: 06/03/2024 SR NO. 46 DAPAGLIFLOZIN TABLETS 5MG | |
|
INDIA | KENYA | 15 |
| 30049099 | ASPER INVOICE NO : ZPPL/XP/2324/407 DATE: 06/03/2024 SR NO. 42 DAPAGLIFLOZIN TABLETS 10MG | |
|
INDIA | KENYA | 100 |
| 30049099 | ASPER INVOICE NO: ZPPL/XP/2324/140 DATE:01/09/2023 SR NO. 29 DAPAGLIFLOZIN TABLETS 10MG | |
|
INDIA | KENYA | 100 |
Why should you choose Eximpedia?
Deep-Analysis Report
Get reports on market trends, price, volume, HS Code supply, product details, country of origin, number of buyers & suppliers, and total shipments with Eximpedia's deep analysis reports.
Access Database Across 130+ Countries
Gain statistical and analytical reports, competitors' shipment records, and country-specific data from over 130 countries.
20 types of unique dashboards
Eximpedia offers 20 types of unique dashboards, tailored to meet diverse business needs. From trade insights to buyer analysis, each dashboard delivers actionable data at your fingertips.
Effortless Global Buyer Discovery
Explore international markets with ease! Access over 5 billion records to identify buyers in 130+ countries with just a click.
Supplier Stability Monitor
Leverage historical shipment data and real-time alerts for a complete view of supplier reliability and performance.
Competitor Pricing Strategy Intelligence
Utilise our data-driven platform to uncover competitors’ pricing strategies and track market pricing trends.